Graphene quantum dots (GQDs) have emerged as a forerunner of carbon nanbiootechnology due to their multifunctional delivery and imaging capabilities as they exhibit fluorescence in the visible and near-infrared, high biocompatibility, and water solubility. These properties put GQDs forward as a compelling drug delivery platform that has already been utilized in a variety of applications including the delivery of chemotherapeutics, antibiotics as well as siRNA and CRISPR-based gene therapy. However, cellular entry pathways of this nanomaterial still remain largely undefined. In a number of studies describing GQD cellular internalization different and, often, conflicting results have been presented due to surveying only few endocytosis inhibitors and disregarding their potential off-target pathways. Understanding the cell internalization routes of GQDs is crucial while delivering drugs in different types of cell lines. Herein, we performed a holistic approach to cell uptake studies on GQDs of different charges by the comparative study of their preferred endocytosis paths in non-cancerous (HEK-293) and cancerous (HeLa) cell lines. The concentration and cell viability of GQDs were determined by MTT assays, while their endocytosis paths were investigated through confocal fluorescence microscopy on cells treated for up to 24 hours. The potential for GQD interactions with the cell membrane was also examined via zeta (ζ) potential measurements. Our findings provide insights into the internalization mechanisms of the GQDs into cell membranes of healthy and cancer cells. The optimization of these mechanisms can serve for the enhancement of a variety of novel GQD applications in biomedicine including therapeutic delivery, disease detection through sensing as well as diagnostic imaging.